A groundbreaking personalized mRNA vaccine, paired with Keytruda, has shown remarkable success in preventing melanoma recurrence after surgery. A large clinical trial reveals that patients could remain cancer-free for years, thanks to this innovative treatment. The vaccine, tailored to the unique genetic fingerprint of each patient's tumor, trains the immune system to detect and destroy cancer cells before they resurface....
This article was AI-summarized from Sciencenews.org. Read original on Sciencenews.org